TREATMENT PHARMA ApS: Financial statements 2019
CVR: 37208035
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
TREATMENT PHARMA ApS (CVR 37208035) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -3,443 and a net result of DKK -5,045 compared with DKK -52,865 the year before. Equity in the 2019 report amounted to DKK -165,365. The company had 1 employee in the financial year.
- Gross Profit
- DKK -3,443
- Profit/Loss
- DKK -5,045
- Equity
- DKK -165,365
- Total Assets
- DKK 1,251
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -3 t. | -5 t. | -165 t. | 1 |
| 2018 | - | -7 t. | -53 t. | -160 t. | - |
| 2017 | - | -10 t. | -12 t. | -107 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
TREATMENT PHARMA ApS has published its annual report for 2018. Gross profit came to DKK -6,740, and the net result was DKK -52,865.
About TREATMENT PHARMA ApS
TREATMENT PHARMA ApS is a Danish company of the type Anpartsselskab based in Horsens, founded in 2015. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named TREATMENT ApS. The management consists of Anne Simmenæs. The company is owned by Tove Resen Holding ApS, Power the Future ApS and Anne Simmenæs Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 410,337 and a net result of DKK 101,980 compared with DKK -38,290 the year before. Equity in the 2025 report amounted to DKK 187,516.